|
US10323236B2
(en)
|
2011-07-22 |
2019-06-18 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US9228207B2
(en)
|
2013-09-06 |
2016-01-05 |
President And Fellows Of Harvard College |
Switchable gRNAs comprising aptamers
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
WO2015105955A1
(en)
|
2014-01-08 |
2015-07-16 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
US10077453B2
(en)
|
2014-07-30 |
2018-09-18 |
President And Fellows Of Harvard College |
CAS9 proteins including ligand-dependent inteins
|
|
BR112017017812A2
(en)
|
2015-02-23 |
2018-04-10 |
Crispr Therapeutics Ag |
Materials and methods for treatment of hemoglobinopathies
|
|
WO2016135559A2
(en)
|
2015-02-23 |
2016-09-01 |
Crispr Therapeutics Ag |
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
US11572543B2
(en)
*
|
2015-05-08 |
2023-02-07 |
The Children's Medical Center. Corporation |
Targeting BCL11A enhancer functional regions for fetal hemoglobin reinduction
|
|
CA2986310A1
(en)
|
2015-05-11 |
2016-11-17 |
Editas Medicine, Inc. |
Optimized crispr/cas9 systems and methods for gene editing in stem cells
|
|
AU2016261927B2
(en)
*
|
2015-05-12 |
2022-04-07 |
Sangamo Therapeutics, Inc. |
Nuclease-mediated regulation of gene expression
|
|
CN108026526B
(zh)
|
2015-06-09 |
2023-05-12 |
爱迪塔斯医药公司 |
用于改善移植的crispr/cas相关方法和组合物
|
|
IL310721B2
(en)
|
2015-10-23 |
2025-11-01 |
Harvard College |
Nucleobase editors and uses thereof
|
|
US12043843B2
(en)
|
2015-11-04 |
2024-07-23 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of hemoglobinopathies
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
CN110214183A
(zh)
|
2016-08-03 |
2019-09-06 |
哈佛大学的校长及成员们 |
腺苷核碱基编辑器及其用途
|
|
WO2018031683A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
CN109844126A
(zh)
|
2016-09-28 |
2019-06-04 |
诺华股份有限公司 |
基于多孔膜的大分子递送系统
|
|
KR102622411B1
(ko)
|
2016-10-14 |
2024-01-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
TW201839136A
(zh)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
治療血色素異常症之組合物及方法
|
|
US12390514B2
(en)
|
2017-03-09 |
2025-08-19 |
President And Fellows Of Harvard College |
Cancer vaccine
|
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
|
US11542496B2
(en)
|
2017-03-10 |
2023-01-03 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
WO2018170184A1
(en)
|
2017-03-14 |
2018-09-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
KR20240116572A
(ko)
|
2017-03-23 |
2024-07-29 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
|
|
US20210380937A1
(en)
|
2017-04-04 |
2021-12-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Preparation , expansion, and uses of adult pluripotent stem cells
|
|
US12110499B2
(en)
|
2017-04-24 |
2024-10-08 |
Seattle Children's Hospital |
Homology directed repair compositions for the treatment of hemoglobinopathies
|
|
EP3622070A2
(en)
*
|
2017-05-10 |
2020-03-18 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease systems and methods
|
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
|
US11788087B2
(en)
*
|
2017-05-25 |
2023-10-17 |
The Children's Medical Center Corporation |
BCL11A guide delivery
|
|
US20200140896A1
(en)
|
2017-06-30 |
2020-05-07 |
Novartis Ag |
Methods for the treatment of disease with gene editing systems
|
|
US11866726B2
(en)
|
2017-07-14 |
2024-01-09 |
Editas Medicine, Inc. |
Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
KR102832035B1
(ko)
|
2017-09-29 |
2025-07-09 |
인텔리아 테라퓨틱스, 인크. |
지질 나노파티클을 이용한 mRNA 전달의 체외 방법
|
|
CN109706148A
(zh)
*
|
2017-09-30 |
2019-05-03 |
广东赤萌医疗科技有限公司 |
一种用于敲除BCL11A基因或者BCL11A基因增强子的gRNA、gRNA组合物以及电转方法
|
|
KR20250107288A
(ko)
|
2017-10-16 |
2025-07-11 |
더 브로드 인스티튜트, 인코퍼레이티드 |
아데노신 염기 편집제의 용도
|
|
MA50849A
(fr)
*
|
2017-10-26 |
2020-09-02 |
Vertex Pharma |
Substances et procédés pour le traitement d'hémoglobinopathies
|
|
CN109722414A
(zh)
*
|
2017-10-27 |
2019-05-07 |
博雅辑因（北京）生物科技有限公司 |
一种高效制备成熟红细胞的方法以及用于制备成熟红细胞的培养基
|
|
EP3704245A1
(en)
|
2017-11-01 |
2020-09-09 |
Novartis AG |
Synthetic rnas and methods of use
|
|
MX2020005235A
(es)
*
|
2017-11-16 |
2020-08-24 |
Mogam Inst Biomedical Res |
Celula humana transformada y uso de la misma.
|
|
WO2019106522A1
(en)
*
|
2017-11-28 |
2019-06-06 |
Novartis Ag |
Pooled crispr/cas9 screening in primary cells using guide swap technology
|
|
AU2018378479B2
(en)
*
|
2017-12-05 |
2025-03-13 |
Vertex Pharmaceuticals Incorporated |
CRISPR-Cas9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof
|
|
KR102439221B1
(ko)
|
2017-12-14 |
2022-09-01 |
프로디자인 소닉스, 인크. |
음향 트랜스듀서 구동기 및 제어기
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
US20200338132A1
(en)
*
|
2018-01-03 |
2020-10-29 |
Magenta Therapeutics Inc. |
Compositions and methods for the expansion of hematopoietic stem and progenitor cells and treatment of inherited metabolic disorders
|
|
WO2019147302A1
(en)
*
|
2018-01-26 |
2019-08-01 |
Bauer Daniel E |
Targeting bcl11a distal regulatory elements with a cas9-cas9 fusion for fetal hemoglobin reinduction
|
|
US11268077B2
(en)
|
2018-02-05 |
2022-03-08 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of hemoglobinopathies
|
|
US11566236B2
(en)
|
2018-02-05 |
2023-01-31 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of hemoglobinopathies
|
|
KR102907245B1
(ko)
|
2018-03-14 |
2026-01-05 |
에디타스 메디신, 인코포레이티드 |
혈색소병증 치료를 위한 시스템 및 방법
|
|
WO2019213273A1
(en)
*
|
2018-05-01 |
2019-11-07 |
The Children's Medical Center Corporation |
Enhanced bcl11a rnp / crispr delivery & editing using a 3xnls-cas9
|
|
WO2019213013A1
(en)
|
2018-05-02 |
2019-11-07 |
The Children's Medical Center Corporation |
Improved bcl11a micrornas for treating hemoglobinopathies
|
|
WO2019213910A1
(en)
*
|
2018-05-10 |
2019-11-14 |
Syngenta Participations Ag |
Methods and compositions for targeted editing of polynucleotides
|
|
KR20210045360A
(ko)
|
2018-05-16 |
2021-04-26 |
신테고 코포레이션 |
가이드 rna 설계 및 사용을 위한 방법 및 시스템
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
US12522807B2
(en)
|
2018-07-09 |
2026-01-13 |
The Broad Institute, Inc. |
RNA programmable epigenetic RNA modifiers and uses thereof
|
|
CN112739208A
(zh)
*
|
2018-09-21 |
2021-04-30 |
艾普斯丹医疗公司 |
人类多能成体干细胞
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
EP3887521A1
(en)
*
|
2018-11-29 |
2021-10-06 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
WO2020191233A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
US12473543B2
(en)
|
2019-04-17 |
2025-11-18 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
CN111939271A
(zh)
*
|
2019-04-30 |
2020-11-17 |
博雅辑因（北京）生物科技有限公司 |
一种血红蛋白病治疗有效性预测方法
|
|
AU2020265060A1
(en)
*
|
2019-04-30 |
2021-12-16 |
Edigene (Guangzhou) Inc. |
Method for predicting effectiveness of treatment of hemoglobinopathy
|
|
WO2020264532A1
(en)
*
|
2019-06-28 |
2020-12-30 |
Asc Therapeutics Inc. |
Methods and compositions for treating thalassemia or sickle cell disease
|
|
CN114364799B
(zh)
*
|
2019-08-28 |
2024-07-19 |
甘李药业股份有限公司 |
编辑造血干/祖细胞中bcl11a基因的方法
|
|
EP4017980A4
(en)
*
|
2019-09-30 |
2024-08-07 |
The Children's Medical Center Corporation |
BCL11A GUIDE AND BASIC EDITOR DISTRIBUTION
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
IL297761A
(en)
|
2020-05-08 |
2022-12-01 |
Broad Inst Inc |
Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
|
|
CN114149990A
(zh)
*
|
2020-09-08 |
2022-03-08 |
甘李药业股份有限公司 |
编辑造血干/祖细胞中bcl11a基因的方法
|
|
US12079386B2
(en)
|
2020-09-14 |
2024-09-03 |
Zebra Technologies Corporation |
Devices having protective screens selectively positionable to switch devices between user interface modes and methods of operating the same
|
|
US20240245725A1
(en)
*
|
2021-05-13 |
2024-07-25 |
The Children's Medical Center Corporation |
Methods for stratifying subjects for fetal hemoglobin reinduction
|
|
CN113584167B
(zh)
*
|
2021-07-07 |
2023-10-03 |
武汉大学中南医院 |
一种用于检测FLT3-F691L突变的crRNA、等温扩增引物和试剂盒
|
|
EP4273242A1
(en)
*
|
2022-05-03 |
2023-11-08 |
ETH Zurich |
Crispr-based modification of human hbd gene
|
|
WO2023214512A1
(ja)
|
2022-05-06 |
2023-11-09 |
学校法人常翔学園 |
人工ｒｎａ分子
|
|
JP2025526403A
(ja)
*
|
2022-07-25 |
2025-08-13 |
セリントラ・セラピューティクス・エスア |
ゲノム編集のための組成物及び方法
|
|
US20240229021A9
(en)
*
|
2022-10-21 |
2024-07-11 |
Georgia Tech Research Corporation |
Transcriptional programming in a bacteroides consortium
|
|
CN116445402B
(zh)
*
|
2023-05-09 |
2025-04-25 |
中国科学院生态环境研究中心 |
红系祖细胞的扩增培养基、扩增培养方法及应用
|
|
WO2025128871A2
(en)
|
2023-12-13 |
2025-06-19 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025174765A1
(en)
|
2024-02-12 |
2025-08-21 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|